ER
BEAT

Enlightenment Research’s BioTelemetry, Inc. BEAT Stock Holding History

Enlightenment Research’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-400
Closed -$24K – 817
2018
Q4 		$24K Buy
+400
New +$24K 0.03% 420

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Enlightenment Research's BEAT Position: Q1 2019 in Review

Enlightenment Research sold out of BioTelemetry, Inc. (BEAT) in Q1 2019, closing a stake of 400 shares — an estimated $24K sold.

Enlightenment Research first reported a position in BEAT in Q4 2018 and held it in 1 quarter. The position peaked at $24K in Q4 2018. 311 funds tracked by Wall St. Rank hold BEAT as of Q1 2019.

  • Enlightenment Research reported no remaining BioTelemetry, Inc. position as of Q1 2019 after selling out during the quarter.
  • Enlightenment Research sold 400 BioTelemetry, Inc. shares in Q1 2019, an estimated $24K.
  • Enlightenment Research first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 1 quarter.
  • Enlightenment Research's BioTelemetry, Inc. position peaked at $24K in Q4 2018.
  • 311 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2019.

Based on Enlightenment Research's 13F filing for Q1 2019, filed 3 May 2019.